WallStSmart

Alcon AG (ALC)vsDentsply Sirona Inc (XRAY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Alcon AG generates 183% more annual revenue ($10.40B vs $3.68B). ALC leads profitability with a 9.4% profit margin vs -16.3%. XRAY appears more attractively valued with a PEG of 0.77. XRAY earns a higher WallStSmart Score of 56/100 (C).

ALC

Hold

49

out of 100

Grade: D+

Growth: 4.7Profit: 5.0Value: 7.3Quality: 7.3
Piotroski: 4/9

XRAY

Buy

56

out of 100

Grade: C

Growth: 5.3Profit: 3.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ALCSignificantly Overvalued (-489.8%)

Margin of Safety

-489.8%

Fair Value

$13.46

Current Price

$75.26

$61.80 premium

UndervaluedFair: $13.46Overvalued

Intrinsic value data unavailable for XRAY.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALC2 strengths · Avg: 8.5/10
Debt/EquityHealth
0.249/10

Conservative balance sheet, low leverage

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

XRAY2 strengths · Avg: 8.0/10
PEG RatioValuation
0.778/10

Growing faster than its price suggests

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Areas to Watch

ALC4 concerns · Avg: 3.3/10
PEG RatioValuation
1.704/10

Expensive relative to growth rate

P/E RatioValuation
37.5x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
4.5%3/10

ROE of 4.5% — below average capital efficiency

EPS GrowthGrowth
-22.2%2/10

Earnings declined 22.2%

XRAY3 concerns · Avg: 2.0/10
Operating MarginProfitability
1.8%3/10

Operating margin of 1.8%

Return on EquityProfitability
-36.4%2/10

ROE of -36.4% — below average capital efficiency

Profit MarginProfitability
-16.3%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : ALC

The strongest argument for ALC centers on Debt/Equity, Price/Book.

Bull Case : XRAY

The strongest argument for XRAY centers on PEG Ratio, Price/Book. PEG of 0.77 suggests the stock is reasonably priced for its growth.

Bear Case : ALC

The primary concerns for ALC are PEG Ratio, P/E Ratio, Return on Equity.

Bear Case : XRAY

The primary concerns for XRAY are Operating Margin, Return on Equity, Profit Margin.

Key Dynamics to Monitor

ALC profiles as a value stock while XRAY is a turnaround play — different risk/reward profiles.

XRAY carries more volatility with a beta of 0.93 — expect wider price swings.

ALC is growing revenue faster at 8.6% — sustainability is the question.

ALC generates stronger free cash flow (489M), providing more financial flexibility.

Bottom Line

XRAY scores higher overall (56/100 vs 49/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alcon AG

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.

Visit Website →

Dentsply Sirona Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Dentsply Sirona is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries.

Want to dig deeper into these stocks?